RENOVA 0.05% Rx
Generic Name and Formulations:
Tretinoin 0.05%; crm.
Valeant Pharmaceuticals, Inc
Indications for RENOVA 0.05%:
Adjunct to comprehensive skin care and sunlight avoidance programs in the palliation of fine wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin.
≥18 years: Wash face with mild soap, pat dry and wait 20–30 minutes before use. Apply a small amount to cover entire affected area lightly once daily in the PM. Do not wash face, or use other skin care products for at least 1 hour after application. Discontinue if sensitivity, irritation, or systemic reactions occur.
<18yrs: not recommended.
Do not use on sunburn, eczema, other chronic skin conditions, or for sun-sensitive patients. Avoid eyes, ears, mouth, angle of nose, mucous membranes, sun, UV light. Increased irritation in extreme weather. Elderly. Pregnancy (Cat.C), nursing mothers: not recommended.
Avoid photosensitizers, topical irritants, and drying agents.
Local erythema, peeling, dry skin, burning, stinging, pruritus, hypo- or hyperpigmentation.
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- FDA Approves Minimally-Invasive, Non-Drug Therapy for Pain Management
- Chronic Migraine and Medication Overuse Headache Linked to Stress
- Set of Personality Traits May Predict Prescription Drug Use, Misuse in Young Adults
- The Opioid Crisis: District by District
- Opioid Administration, Prescribing in the ED on the Decline in Recent Years